Epigenomics AG
F:ECX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Epigenomics AG
F:ECX1
|
DE |
|
A
|
Arcos Dorados Holdings Inc
SWB:AD8
|
UY |
|
Nippon Gas Co Ltd
F:NG0
|
JP |
|
Gruma SAB de CV
OTC:GPAGF
|
MX |
|
Nuformix PLC
F:1RT
|
UK |
|
Celadon Group Inc
F:CG2
|
US |
|
M
|
Mito Securities Co Ltd
F:896
|
JP |
|
I
|
Istyle Inc
F:IY5
|
JP |
|
Dongfeng Motor Group Co Ltd
F:D4D
|
CN |
|
R
|
Roadman Investments Corp
OTC:RMANF
|
CA |
|
B
|
BMP Pharma Trading AG
SWB:BMP
|
DE |
|
N
|
Noram Lithium Corp
XBER:N7R
|
CA |
|
Fast Finance 24 Holding AG
F:FF24
|
DE |
|
Burning Rock Biotech Ltd
NASDAQ:BNR
|
CN |
|
Shadowfax Technologies Ltd
NSE:SHADOWFAX
|
IN |
|
C
|
Condor Petroleum Inc
F:1CN1
|
CA |
|
O
|
Oshkosh Corp
XBER:OK3
|
US |
|
S
|
Sihayo Gold Ltd
F:ORY
|
AU |
|
Phoenix Copper Ltd
OTC:PXCLF
|
VG |
|
Casino Guichard Perrachon SA
PAR:CO
|
FR |
Bankruptcy Probability
Epigenomics AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Epigenomics AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Epigenomics AG
XETRA:ECX
|
1.3m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
464.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
238.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
59.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Epigenomics AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Epigenomics AG has total debt of 517k EUR. This includes both short-term (0 EUR) and long-term (517k EUR) debt.
You can find a full breakdown on its Balance Sheet.
